As filed with the Securities and Exchange Commission on March 31, 2000
                                                    Registration No. 333-
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                               ----------------
                                   FORM SB-2
                            REGISTRATION STATEMENT
                                     Under
                          THE SECURITIES ACT OF 1933

                               ----------------
                          BentleyCapitalCorp.com Inc.
             (Exact name of small business issuer in its charter)


                                                           
           Washington                          5499                        91-2022700
 (State or other jurisdiction of        (primary standard               (I.R.S. Employer
 incorporation or organization)          industrial code)            Identification Number)


                        1177 West Hastings, Suite 2110
                  Vancouver, British Columbia V6E 2K3, CANADA
                                (604) 687-2199
         (Address and telephone number of principal executive offices)

                               ----------------

                                            
             Agent for Service:                               With a Copy to:
          Michael Kirsh, President                           James L. Vandeberg
         BentleyCapitalCorp.com Inc.                     Ogden Murphy Wallace, PLLC
       1177 West Hastings, Suite 2110                  1601 Fifth Avenue, Suite 2100
 Vancouver, British Columbia V6E 2K3, CANADA             Seattle, Washington 98101
               (604) 687-2199                                  (206) 447-7000

(Name, address, including zip code, and telephone number, including area code,
                             of agent for service)

Approximate date of commencement of proposed sale to the public: As soon as
practicable after the effective date of this Registration Statement.

  If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [_]

  If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]

  If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]

  If delivery of the prospectus is expected to be made pursuant to Rule 434,
check the following box. [_]
                        CALCULATION OF REGISTRATION FEE

- ---------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------

                                                     Proposed       Proposed
                                       Amount        maximum        maximum       Amount of
     Title of each class of            to be      offering price   aggregate     registration
   securities to be registered       registered      per unit    offering price      fee
- ---------------------------------------------------------------------------------------------
                                                                    
Class A Common Stock............      500,000          $.01        $5,000.00        $1.32
- ---------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------


- -------------------------------------------------------------------------------
Note: Specific details relating to the fee calculation shall be furnished in
notes to the table, including references to provisions of Rule 457 (Section
230.457 of this chapter) relied upon, if the basis of the calculation is not
otherwise evident from the information presented in the table. If the filing
fee is calculated pursuant to Rule 457(o) under the Securities Act, only the
title of the class of securities to be registered, the proposed maximum
aggregate offering price for that class of securities and the amount of
registration fee needed to appear in the Calculation of Registration Fee
table. Any difference between the dollar amount of securities registered for
such offerings and the dollar amount of securities sold may be carried forward
on a future registration statement pursuant to Rule 429 under the Securities
Act.
- -------------------------------------------------------------------------------
  The registration hereby amends this registration statement on such date or
dates as may be necessary to delay its effective date until the registrant
shall file a further amendment which specifically states that this
registration statement shall thereafter become effective in accordance with
Section 8(a) of the Securities Act of 1933 or until the registration statement
shall become effective on such date as the Commission, acting pursuant to said
Section 8(a), may determine.


++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+WE WILL AMEND AND COMPLETE THE INFORMATION IN THIS PROSPECTUS. THE            +
+INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT +
+SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE         +
+SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN    +
+OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE +
+SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.             +
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

                   SUBJECT TO COMPLETION--[enter date, 2000]

PROSPECTUS

                                         , 2000

                          BentleyCapitalCorp.com Inc.

                         1177 West Hastings, Suite 2110
                  Vancouver, British Columbia V6E 2K3, CANADA
                                 (604) 687-2199

                         500,000 Shares of Common Stock
                   to be sold by BentleyCapitalCorp.com Inc.

  This is the initial public offering of common stock of BentleyCapitalCorp.com
Inc., and no public market currently exists for shares of
BentleyCapitalCorp.com's common stock. The price for the stock will be fixed.
BentleyCapitalCorp.com has no revenues to date and there may not be a market
for the products it plans to sell.

  This is not an underwritten offering, and BentleyCapitalCorp.com's stock is
not listed on any national securities exchange or the NASDAQ Stock Market.
BentleyCapitalCorp.com intends to apply to have its shares traded on the OTC
bulletin board under the symbol:

                                     "BCCC"

                                  -----------

                THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK.
                   SEE "RISK FACTORS" BEGINNING ON PAGE    .

                                  -----------

  Neither the SEC nor any state securities commission has approved or
disapproved of these securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal offense.

  You should rely only on the information contained in this document.
BentleyCapitalCorp.com has not authorized anyone to provide you with
information that is different. This document may only be used where it is legal
to sell these securities. The information in this document may only be accurate
on the date of this document.


                               TABLE OF CONTENTS



                                                                           Page
                                                                           ----
                               PART I--PROSPECTUS

                                                                        
PROSPECTUS SUMMARY........................................................   1
RISK FACTORS..............................................................   2
  BentleyCapitalCorp.com Is In Its Earliest Stages of Development and May
   Never Become Profitable................................................   2
  Conflicts of Interest May Arise Between Companies Owned by the Sole
   Shareholder............................................................   2
  BentleyCapitalCorp.com May Lose Its Vitamineralherb License if
   Vitamineralherb.com Defaults Under Its Agreementwith Its Supplier......   2
  Dependence on Use of the Internet for Commerce..........................   3
  Dependence on the Internet and Computer Technology......................   3
  Dependence on Telecommunications Carrier and Other Suppliers............   3
  Government Regulation of the Internet Could Adversely Affect
   BentleyCapitalCorp.com's Profitability.................................   4
  Government Regulation of Products Could Adversely Affect Viability of
   Dietary Supplements....................................................   4
  Heavy Dependence on One Individual Who Will Not Devote His Full time and
   Attention to BentleyCapitalCorp.com's Affairs Could Result in Delays or
   Business Failure.......................................................   5
  Heavy Dependence on One Individual Who Has No Experience in the Retail
   Vitamin Line of Business...............................................   5
  Product Liability.......................................................   5
  Effect of Unfavorable Publicity.........................................   6
  Ability to Manage Growth................................................   6
  Absence of Conclusive Clinical Studies..................................   6
  Competition.............................................................   6
  No Assurance of Future Industry Growth..................................   7
  Potential Business Combinations Dilute Stockholder Value................   7
  Potential Business Combinations Could Be Difficult to Integrate and
   Disrupt Business.......................................................   7
  BentleyCapitalCorp.com May Enter in to New Line of Business Which
   Investors Could Not Evaluate...........................................   7
  BentleyCapitalCorp.com Has No Operating History and Financial Results
   Are Uncertain..........................................................   8
  BentleyCapitalCorp.com May Need Additional Financing Which May Not Be
   Available or Which May Dilute the Ownership Interests of Investors.....   8
  BentleyCapitalCorp.com's Common Stock Has No Prior Market, and Prices
   May Decline After the Offering.........................................   9
  Investors May Face Significant Restrictions on the Resale of
   BentleyCapitalCorp.com Stock Due to State Blue Sky Laws................   9
  Investors May Face Significant Restrictions on the Resale Of
   BentleyCapitalCorp.com Stock Due to Federal Penny Stock Regulations....   9
USE OF PROCEEDS...........................................................  10
DETERMINATION OF OFFERING PRICE...........................................  10
DILUTION..................................................................
SELLING SECURITY HOLDERS..................................................  10
PLAN OF DISTRIBUTION......................................................  11
LEGAL PROCEEDINGS.........................................................  11
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS..............  11
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT............  12
DESCRIPTION OF SECURITIES.................................................  12
INTEREST OF NAMED EXPERTS AND COUNSEL.....................................  12
DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT
 LIABILITIES..............................................................  13





                                                                           Page
                                                                           ----
                                                                        
DESCRIPTION OF BUSINESS..................................................    13
MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION................    20
DESCRIPTION OF PROPERTY..................................................    21
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS...........................    21
MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.................    21
EXECUTIVE COMPENSATION...................................................    22
FINANCIAL STATEMENTS.....................................................   F-1
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
 DISCLOSURE..............................................................   F-7


                PART II--INFORMATION NOT REQUIRED IN PROSPECTUS

INDEMNIFICATION OF DIRECTORS AND OFFICERS................................  II-1
OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION..............................  II-1
RECENT SALES OF UNREGISTERED SECURITIES..................................  II-1
EXHIBITS.................................................................  II-2
UNDERTAKINGS.............................................................  II-2



                               PART I--PROSPECTUS

                               PROSPECTUS SUMMARY

  The following summary is qualified in its entirety by and should be read in
conjunction with the more detailed information and the Financial Statements and
notes thereto appearing elsewhere in this Prospectus.

BentleyCapitalCorp.com

  BentleyCapitalCorp.com Inc. is a corporation formed under the laws of the
State of Washington, whose principal executive offices are located in
Vancouver, British Columbia, Canada.

  The primary objective of the business is designed to market high-quality,
low-cost vitamins, minerals, nutritional supplements, and other health and
fitness products to medical professionals, alternative health professionals,
martial arts studios and instructors, sports and fitness trainers, other health
and fitness professionals, school and other fund raising programs and other
similar types of customers via the Internet for sale to their clients.

  In a License Agreement with Vitamineralherb.com, filed herewith as Exhibit
10.1, BentleyCapitalCorp.com acquired the exclusive right to distribute
Vitamineralherb.com products to health and fitness professionals for sale to
their customers in Ontario via the Internet. BentleyCapitalCorp.com's goal in
becoming a Vitamineralherb.com licensee is to eliminate the need to develop
products, store inventory, build and maintain a web-site, establish banking
liaisons, and develop a fulfillment system, thereby enabling
BentleyCapitalCorp.com to focus strictly on marketing and sales. All sales are
conducted over the Internet through Vitamineralherb.com's website. Health and
fitness professionals may order a variety of products, and may have the
products custom-labeled. Products are shipped directly to the client.
BentleyCapitalCorp.com and Vitamineralherb.com share the profit on product
sales.

Background on the Manufacturer and Distributor

  On June 9, 1999, Vitamineralherb.com entered into a manufacturing agreement
with International Formulation and Manufacturing Inc., a nutraceuticals
manufacturing firm, located in San Diego, California, USA. International
Formulation and Manufacturing Inc. is a contract manufacturer of vitamin,
mineral, nutritional supplement, and alternative health products for various
marketing organizations. In addition to a line of standard products,
International Formulation and Manufacturing Inc. is able to manufacture custom
blended products for customers, and to supply privately labeled products for
BentleyCapitalCorp.com's customers at a minimal added cost.

Market Opportunity

  The vitamins, supplements and minerals market is projected to grow as the
"baby boomer" population becomes increasingly concerned with aging and disease,
preventative health care and natural products. According to Jupiter
Communications, online sales of such products are expected to be US $434
million in the year 2003, up from $1 million in 1998. For additional
information, see "Business--Industry Background."

Name, Address, and Telephone Number of Registrant

  BentleyCapitalCorp.com Inc.
  1177 West Hastings, Suite 2110
  Vancouver, British Columbia V6E 2K3, CANADA
  (604) 687-2199
  (604) 687-8360

The Offering

  BentleyCapitalCorp.com is offering up to 500,000 shares of its common stock
at $.01 per share. Ucellit.com is simultaneously applying to the OTC Bulletin
Board along with filing with the SEC.

                                       1


                                 RISK FACTORS

  You should carefully consider the following risk factors and all other
information contained in this prospectus before purchasing the common stock of
BentleyCapitalCorp.com. Investing in BentleyCapitalCorp.com's common stock
involves a high degree of risk. Any of the following risks could adversely
affect BentleyCapitalCorp.com's business, financial condition and results of
operations and could result in a complete loss of your investment.

You Should Not Rely on Forward-Looking Statements Because They Are Inherently
Uncertain

  You should not rely on forward-looking statements in this prospectus. This
prospectus contains forward-looking statements that involve risks and
uncertainties. We use words such as "anticipates", "believes", "plans",
"expects", "future", "intends" and similar expressions to identify these
forward-looking statements. Prospective investors should not place undue
reliance on forward-looking statements, which apply only as of the date of
this prospectus. BentleyCapitalCorp.com's actual results could differ
materially from those anticipated in these forward-looking statements for many
reasons, including the risks faced by BentleyCapitalCorp.com described in
"Risk Factors" and elsewhere in this prospectus.

Risks Related to BentleyCapitalCorp.com's Business

  BentleyCapitalCorp.com's success is dependent on a number of factors that
should be considered by prospective investors. BentleyCapitalCorp.com has only
recently acquired its principal asset. It is a new company and has no history
of earnings or profit and there is no assurance that it will operate
profitably in the future. As such, there is no assurance that
BentleyCapitalCorp.com will provide a return on investment in the future.

 BentleyCapitalCorp.com Is in Its Earliest Stages of Development and May Never
 Become Profitable

  BentleyCapitalCorp.com is in the extreme early stages of development and
could fail before implementing its business plan. It must be regarded as a
"start up" venture that will incur net losses for the foreseeable future.
BentleyCapitalCorp.com has no operating history or revenues from operations,
and it faces unforeseen costs, expenses, problems and difficulties that could
easily prevent it from ever becoming profitable. BentleyCapitalCorp.com's
success is dependent on a number of factors that should be considered by
prospective investors. BentleyCapitalCorp.com has only recently acquired its
principal asset. It is a relatively young company and has no history of
earnings or profit and there is no assurance that it will operate profitably
in the future. As such, there is no assurance that BentleyCapitalCorp.com will
provide a return on investment in the future.

 Conflicts of Interest May Arise Between Companies Owned by the Sole
 Shareholder

  Michael Kirsh, the sole shareholder, officer and director of
BentleyCapitalCorp.com, is also the sole shareholder, officer and director of
Ucellit.com, a company with a Vitamineralherb.com license for the territory of
Ontario, Canada. The license for Ontario territory may prove more lucrative
than BentleyCapitalCorp.com's British Columbia territory, and it is possible
that Mr. Kirsh could devote more time and resources to the company that is
more likely to succeed.

 BentleyCapitalCorp.com May Lose Its Vitamineralherb License if
 Vitamineralherb.com Defaults Under Its Agreement with Its Supplier

  Vitamineralherb.com granted the distribution license to
BentleyCapitalCorp.com based on Vitamineralherb.com's Manufacturing Agreement
with International Formulation and Manufacturing Inc. If Vitamineralherb.com
defaults under its agreement with International Formulation and Manufacturing
Inc., it could lose access to its manufacturing source, and the rights
Vitamineralherb.com has granted BentleyCapitalCorp.com would become
meaningless. Similarly, any dispute between International Formulation and
Manufacturing Inc. and Vitamineralherb.com (or their successors) could impair
BentleyCapitalCorp.com's ability to fully exploit its license rights. Any
termination or impairment of BentleyCapitalCorp.com's license

                                       2


rights due to circumstances under the control of International Formulation and
Manufacturing Inc., Vitamineralherb.com or others with an interest in the
products could prevent BentleyCapitalCorp.com from implementing its business
plan, thereby limiting its profitability and decreasing the value of its
stock.

 Dependence on Use of the Internet for Commerce

  If use of the Internet and growth of the market for online vitamins,
supplements, minerals and other similar products do not continue,
BentleyCapitalCorp.com may not achieve the critical mass of customers
necessary for sustaining revenues and achieving profitable operations.
BentleyCapitalCorp.com's future revenues and profits, if any, substantially
depend upon the widespread acceptance and use of the Internet as an effective
medium of business by target consumers. Rapid growth in the use of and
interest in the Internet has occurred only recently. As a result, acceptance
and use may not continue to develop at historical rates, and a sufficiently
broad base of consumers may not use the Internet and other online services as
a medium of commerce. Further, the online market for such products is in its
infancy, and is significantly less developed than the online market for books,
auctions, music, software and numerous other consumer products. Even if use of
the Internet and electronic commerce continues to increase, the rate of
growth, if any, of the online vitamins, supplements, minerals and other
similar products market could be significantly less than the online market for
other products. BentleyCapitalCorp.com's rate of revenue growth and prospects
for profitability could therefore be significantly less than that of other
online merchants.

 Dependence on the Internet and Computer Technology

  The market for Internet access is characterized by rapidly changing
technology, evolving industry standards, changes in users' needs and frequent
new service introductions. BentleyCapitalCorp.com's future success will
depend, in part, on Vitamineralherb.com's use of leading technologies to
provide seamless access to and services through its Website. There can be no
assurance that Vitamineralherb.com will be successful in using new
technologies effectively, developing new services or enhancing existing
services on a timely basis.

  BentleyCapitalCorp.com's success also depends on continued use and expansion
of the Internet. The Internet infrastructure may not be able to support the
demands placed on it by continued growth. The growth in volume of Internet
traffic may create instabilities in its structure such as shortages in
Internet addresses and overworked search engines. Such instabilities may have
an adverse affect on BentleyCapitalCorp.com's operations and business if they
are not addressed. The Internet could also lose its viability due to delays in
the development or adoption of new standards and protocols to handle increased
levels of Internet activity, security, reliability, cost, ease of use,
accessibility, and quality of service. Vitamineralherb.com's network
infrastructure may be vulnerable to computer viruses, hacking or similar
disruptive problems caused by users, other connected Internet sites, the
interconnecting networks and the various telephone networks. Computer viruses
or problems caused by third parties could lead to interruptions, delays or
cessation in service to BentleyCapitalCorp.com.

  The Internet may not be accepted as a viable long-term commercial
marketplace for a number of reasons, including potentially inadequate
development of the necessary network infrastructure or delayed development of
enabling technologies and performance improvements. BentleyCapitalCorp.com's
success will depend, in large part, upon third parties maintaining the
Internet infrastructure to provide a reliable network backbone with the speed,
data capacity, security and hardware necessary for reliable Internet access
and services.

 Dependence on Telecommunications Carriers and Other Suppliers

  BentleyCapitalCorp.com will rely on Vitamineralherb.com's providers such as
the local telephone companies and other companies to provide data-
communications via local telecommunications lines and leased long-distance
lines. The means of ordering and paying for products may be disrupted or
eliminated if Vitamineralherb.com experiences disruptions or capacity
constraints in its telecommunications services. There may be no means of
replacing these services on a timely basis or at all.

                                       3


  In addition, the inability or unwillingness of any third-party to provide
point of presence access to BentleyCapitalCorp.com or its inability to secure
alternative point of presence arrangements could significantly limit its
ability to service its existing customers and could limit its ability to
expand to new markets, which could, in turn, have a material adverse effect on
its business, financial condition and results of operations.

 Government Regulation of the Internet Could Adversely Affect
 BentleyCapitalCorp.com's Profitability

  Existing or future legislation could limit growth in use of the Internet,
which would curtail BentleyCapitalCorp.com's revenue growth. Statutes and
regulations directly applicable to Internet communications, commerce and
advertising are becoming more prevalent. The law remains largely unsettled,
however, even in areas where there has been legislative action. It may take
years to determine whether and how existing laws governing intellectual
property, privacy, libel and taxation apply to the Internet, electronic
commerce and online advertising. In addition, the growth and development of
electronic commerce may prompt calls for more stringent consumer protection
laws, in the United States, Canada and abroad. It is possible that Canadian,
U.S., or other local or foreign jurisdictions may seek to impose sales tax
collection obligations on BentleyCapitalCorp.com. If one or more states or any
foreign country successfully asserts that BentleyCapitalCorp.com should
collect sales or other taxes on the sale of its products, it could also
prevent BentleyCapitalCorp.com's business from growing or expose it to
unanticipated liabilities.

  Any new regulation or taxation of Internet commerce could damage
BentleyCapitalCorp.com's business, affect the profitability and perhaps the
viability of its business plan, and cause the price of its common stock to
decline. Such regulation or taxation could prove to be burdensome, and impose
significant additional costs on BentleyCapitalCorp.com's business or subject
it to additional liabilities. As Internet commerce continues to evolve,
increasing regulation by federal, state, or foreign agencies becomes more
likely. Such regulation is likely in the areas of user privacy, pricing,
content, and quality of products and services. Taxation of Internet use, or
other charges imposed by government agencies or by private organizations for
accessing the Internet, may also be imposed. Laws and regulations applying to
the solicitation, collection, or processing of personal or consumer
information could limit BentleyCapitalCorp.com's activities. In addition, any
regulation imposing fees for Internet use could result in a decline in the use
of the Internet and the viability of Internet commerce, which could have a
material adverse effect on BentleyCapitalCorp.com's business, results of
operations, and financial condition.

 Government Regulation of Products Could Adversely Affect Viability of Dietary
 Supplements

  In Canada, extensive federal government regulations may restrict the way
BentleyCapitalCorp.com sells its products, resulting in restrictions on the
products and content BentleyCapitalCorp.com offers its customers and
significant additional expenses. The manufacture, packaging, labeling,
advertising, promotion, distribution and sale of BentleyCapitalCorp.com's
products are subject to regulation by numerous Canadian governmental agencies,
the most active of which is Health Canada, which regulates
BentleyCapitalCorp.com's products under the Food and Drugs Act and associated
regulations.

  Canadian laws, regulations and enforcement policies governing
BentleyCapitalCorp.com's dietary supplement products are relatively new and
still evolving and BentleyCapitalCorp.com cannot predict what enforcement
positions Health Canada or Industry Canada may take with respect to
BentleyCapitalCorp.com's selling methods. Health Canada has established a new
Office of National Health Products (ONHP) which will evaluate health products
for assurance of safety while enhancing consumer access and choice to a full
range of natural health products. ONHP will be a new regulatory authority
reporting to the Assistant Deputy Minister, Health Protections Branch. Until
the new regulatory framework has been established under the ONHP, natural
health products will continue to be regulated either as foods or drugs.

  U.S. federal, state and local government regulations may also restrict
BentleyCapitalCorp.com's products. The manufacture, packaging, labeling,
advertising, promotion, distribution and sale of BentleyCapitalCorp.com's
products are subject to regulation by numerous governmental agencies, the most
active of which is the U.S. Food and Drug Administration, which regulates
BentleyCapitalCorp.com's products under the Federal Food, Drug and

                                       4


Cosmetic Act and regulations promulgated thereunder. BentleyCapitalCorp.com's
products are also subject to regulation by, among other regulatory entities,
the Consumer Product Safety Commission, the U.S. Department of Agriculture,
and the Environmental Protection Agency. Advertising and other forms of
promotion and methods of marketing of BentleyCapitalCorp.com's products are
subject to regulation by the U.S. Federal Trade Commission, which regulates
these activities under the Federal Trade Commission Act. The manufacture,
labeling and advertising of BentleyCapitalCorp.com's products are also
regulated by various state and local agencies as well as those of each foreign
country to which it distributes its products.

  BentleyCapitalCorp.com cannot be certain that its attempts, or those of its
suppliers, to comply with laws and regulations in this area are or will be
deemed sufficient by the appropriate regulatory agencies. Enforcement actions
by any of these regulatory agencies can result in civil and criminal
penalties, an injunction to stop or modify certain selling methods, seizure of
BentleyCapitalCorp.com's products, adverse publicity or voluntary recalls and
labeling changes. If any governmental agency were to undertake an enforcement
action against BentleyCapitalCorp.com, it could cause an immediate decrease in
its revenues, cause it to incur significant additional expenses and result in
a decrease in its stock price. BentleyCapitalCorp.com's efforts to comply with
existing laws and regulations may be costly, may force it to change its
selling strategy and may not be successful. BentleyCapitalCorp.com cannot
promise that it will be able to comply with any existing or future laws,
regulations, interpretations or applications without incurring significant
costs or adjusting its business model. A more detailed discussion of the
government regulations affecting BentleyCapitalCorp.com's business is included
in this prospectus under the heading "Business--Regulatory Environment."

 Heavy Dependence on One Individual Who Will Not Devote His Full Time and
 Attention to BentleyCapitalCorp.com's Affairs Could Result in Delays or
 Business Failure

  Mr. Kirsh is serving as BentleyCapitalCorp.com's sole officer and director.
Loss of Mr. Kirsh's services may hamper BentleyCapitalCorp.com's ability to
implement its business plan, and could cause its stock to be worthless.
BentleyCapitalCorp.com will be heavily dependent upon Mr. Kirsh's
entrepreneurial skills and experience to implement its business plan and may,
from time to time, find that his inability to devote full time and attention
to its affairs will result in delay(s) in progress towards the implementation
of its business plan or in a failure to implement its business plan. Moreover,
BentleyCapitalCorp.com does not have an employment agreement with Mr. Kirsh
and as a result, there is no assurance that he will continue to manage its
affairs in the future. Nor has BentleyCapitalCorp.com obtained a key man life
insurance policy on Mr. Kirsh. BentleyCapitalCorp.com could lose the services
of Mr. Kirsh, or Mr. Kirsh could decide to join a competitor or otherwise
compete directly or indirectly with BentleyCapitalCorp.com, which would have a
significant adverse effect on its business and could cause the price of its
stock to be worthless. The services of Mr. Kirsh would be difficult to
replace. Because investors will not necessarily be able to evaluate the merits
of BentleyCapitalCorp.com's business decisions, they should carefully and
critically assess Mr. Kirsh's background. See "Directors and Executive
Officers".

 Heavy Dependence on One Individual Who Has No Experience in the Retail
 Vitamin Line of Business

  Mr. Kirsh has no experience in marketing and retail sale of vitamins and
other nutritional supplements, or the sale of products over the Internet. Mr.
Kirsh is not a doctor, nutritionist, or health professional by trade. As a
result, BentleyCapitalCorp.com will likely need to rely on others who
understand the sale and marketing of nutritional supplements. Because of lack
of experience in this line of business, BentleyCapitalCorp.com may
overestimate the marketability of the Vitamineralherb.com products and may
underestimate the costs and difficulties associated with selling and
distributing of the products. Any such unanticipated costs or difficulties
could prevent BentleyCapitalCorp.com from implementing its business plan,
thereby limiting its profitability and decreasing the value of its stock.

 Product Liability

  BentleyCapitalCorp.com, like other retailers, distributors and manufacturers
of dietary supplements designed for human consumption, faces an inherent risk
of exposure to product liability claims in the event that

                                       5


the use of its products results in injury. BentleyCapitalCorp.com may be
subjected to various product liability claims, including, among others, that
its products include inadequate instructions for use or inadequate warnings
concerning possible side effects and interactions with other substances.
BentleyCapitalCorp.com relies on third party manufacturers for its products.
BentleyCapitalCorp.com has no product liability insurance coverage. Although
Vitamineralherb.com warrants the products and provides indemnification to
BentleyCapitalCorp.com for losses, claims, and expenses arising from a breach
of the product warranties, any such indemnification is limited by its terms
and, as a practical matter, is limited to the creditworthiness of the
indemnifying party. In the event that BentleyCapitalCorp.com does not have
adequate indemnification, product liabilities relating to its products could
have a material adverse effect on its business, financial condition and
results of operations.

 Effect of Unfavorable Publicity

  BentleyCapitalCorp.com believes the dietary supplement market is affected by
national media attention regarding the consumption of dietary supplements.
Future scientific research or publicity may not be favorable to the dietary
supplement industry or to any particular product, and may not be consistent
with earlier favorable research or publicity. Because of
BentleyCapitalCorp.com's dependence on consumers' perceptions, adverse
publicity associated with illness or other adverse effects resulting from the
consumption of its products or any similar products distributed by other
companies and future reports of research that are perceived as less favorable
or that question earlier research could have a material adverse effect on
BentleyCapitalCorp.com's business, financial condition and results of
operations. BentleyCapitalCorp.com is highly dependent upon consumers'
perceptions of the safety and quality of its products as well as dietary
supplements distributed by other companies. Thus, the mere publication of
reports asserting that such products may be harmful or questioning their
efficacy could have a material adverse effect on BentleyCapitalCorp.com's
business, financial condition and results of operations, regardless of whether
such reports are scientifically supported or whether the claimed harmful
effects would be present at the dosages recommended for such products.

 Ability to Manage Growth

  BentleyCapitalCorp.com's ability to manage growth depends in part upon its
ability to develop and expand operating, management, information and financial
systems, and production capacity, which may significantly increase its future
operating expenses. No assurance can be given that BentleyCapitalCorp.com's
business will grow in the future or that it will be able to effectively manage
such growth. BentleyCapitalCorp.com's inability to manage its growth
successfully could have a material adverse effect on its business, financial
condition and results of operations.

 Absence of Conclusive Clinical Studies

  Although many of the ingredients in BentleyCapitalCorp.com's products are
vitamins, minerals, herbs and other substances for which there is a long
history of human consumption, some of its products contain ingredients for
which no such history exists. In addition, although BentleyCapitalCorp.com
believes all of its products are safe when taken as directed on the product
labeling, there is little long-term experience with human consumption of
certain of these product ingredients in concentrated form. Accordingly, there
can be no assurance that BentleyCapitalCorp.com's products, even when used as
directed, will have the effects intended or will not have harmful side
effects. Any such unintended effects may result in adverse publicity or
product liability claims which could have a material adverse effect on
BentleyCapitalCorp.com's business, financial condition and results of
operations.

 Competition

  The electronic commerce industry is new, rapidly evolving and intensely
competitive, and BentleyCapitalCorp.com expects competition to intensify in
the future. If it fails to attract and retain a large customer base and its
competitors establish a market position more prominent than
BentleyCapitalCorp.com's, it could experience declines in its revenue and a
loss of market share. Barriers to entry are minimal and current

                                       6


and new competitors can launch sites at a relatively low cost. In addition,
the vitamins, supplements, minerals and alternative health products market is
very competitive and highly fragmented, with no clear dominant leader and
increasing public and commercial attention. BentleyCapitalCorp.com competes
with a variety of other companies, including traditional vitamins,
supplements, minerals and alternative health product retailers, the online
retail initiatives of several such traditional retailers and other
Vitamineralherb.com licensees. A more detailed discussion regarding the
competition BentleyCapitalCorp.com faces is included in this prospectus under
the heading "Business--Competition."

 No Assurance of Future Industry Growth

  There can be no assurance that the market is as large as reported in market
data referred to in this prospectus or that such projected growth will occur
or continue. Market data and projections such as those presented in this
prospectus are inherently uncertain, subject to change and often dated. In
addition, the underlying market conditions are subject to change based on
economic conditions, consumer preferences and other factors that are beyond
BentleyCapitalCorp.com's control. An adverse change in size or growth rate of
the market for dietary supplements is likely to have a material adverse effect
on BentleyCapitalCorp.com's business, financial condition and results of
operations.

 Potential Business Combinations Dilute Stockholder Value

  Because BentleyCapitalCorp.com may not be successful in developing a viable
market for the Vitamineralherb.com products, its management will spend a
significant portion of the time it devotes to evaluating other business
opportunities that may be available to BentleyCapitalCorp.com. In the event of
a business combination, the ownership interests of holders of existing shares
of BentleyCapitalCorp.com's stock will be diluted. Due to its limited
financial resources, the only way BentleyCapitalCorp.com will be able to
diversify its activities, should its business plan prove to be impractical,
would be to enter into a business combination.

  Any asset acquisition or business combination would likely include the
issuance of a significant amount of BentleyCapitalCorp.com's common stock,
which would dilute the ownership interest of holders of existing shares, and
may result in a majority of the voting power being transferred to new
investors. Depending on the nature of the transaction,
BentleyCapitalCorp.com's stockholders may not have an opportunity to vote on
whether to approve it. For example, BentleyCapitalCorp.com's board of
directors may decide to issue a significant amount of stock to effect a share
exchange with another company. Such a transaction does not require shareholder
approval, but BentleyCapitalCorp.com's officers and directors must exercise
their powers in good faith and with a view to the interests of the
corporation.

 Potential Business Combinations Could Be Difficult to Integrate and Disrupt
 Business

  Any acquisition of or business combination with another company could
disrupt BentleyCapitalCorp.com's ongoing business, distract management and
employees and increase its expenses. If BentleyCapitalCorp.com acquires a
company, it could face difficulties in assimilating that company's personnel
and operations. In addition, the key personnel of the acquired company may
decide not to work for BentleyCapitalCorp.com. Acquisitions also involve the
need for integration into existing administration, services, marketing, and
support efforts. Any amortization of goodwill or other assets, or other
charges resulting from the costs of these acquisitions, could limit
BentleyCapitalCorp.com's profitability and decrease the value of its stock. In
addition, BentleyCapitalCorp.com's liquidity and capital resources may be
diminished prior to or as a result of consummation of a business combination
and its capital may be further depleted by the operating losses (if any) of
the business entity which BentleyCapitalCorp.com may eventually acquire.

 BentleyCapitalCorp.com May Enter in to New Line of Business Which Investors
 Could Not Evaluate

  In the event of a business combination, acquisition, or change in
shareholder control, BentleyCapitalCorp.com may enter in to a new line of
business which an investor did not anticipate and in which

                                       7


that investor may not want to participate. BentleyCapitalCorp.com may make
investments in or acquire complementary products, technologies and businesses,
or businesses completely unrelated to its current business plan. Similarly, an
asset acquisition or business combination would likely include the issuance of
a significant amount of BentleyCapitalCorp.com's common stock, which may
result in a majority of the voting power being transferred to new investors.
New investors may replace BentleyCapitalCorp.com's management. New management
may decide not to continue to implement BentleyCapitalCorp.com's current
business plan, and may decide to enter into a business completely unrelated to
the current business plan which an investor did not anticipate and in which
that investor may not want to participate. In such case, an investor could
lose its entire investment on a business decision it did not get to evaluate
at the time of investing in BentleyCapitalCorp.com.

Financial Risks

 BentleyCapitalCorp.com Has No Operating History and Financial Results Are
 Uncertain

  BentleyCapitalCorp.com is a young company with no history of earnings or
profit and there is no assurance that it will operate profitably in the
future. BentleyCapitalCorp.com faces all the risks of a new business. As a
result of BentleyCapitalCorp.com's limited operating history, it is difficult
to accurately forecast its potential revenue, and there is no meaningful
historical financial data upon which to base planned operating expenses. Its
revenue and income potential is unproven and its business model is still
emerging. As such, there is no assurance that BentleyCapitalCorp.com will
provide a return on investment in the future. An investor in
BentleyCapitalCorp.com's common stock must consider the challenges, risks and
uncertainties frequently encountered by early-stage companies using new and
unproven business models in new and rapidly evolving markets. These challenges
include our ability to:

  .  execute on BentleyCapitalCorp.com's business model;

  .  create brand recognition;

  .  manage growth in BentleyCapitalCorp.com's operations;

  .  create a customer base cost-effectively;

  .  retain customers;

  .  access additional capital when required;

  .  attract and retain key personnel.

  BentleyCapitalCorp.com cannot be certain that its business model will be
successful or that it will successfully address these and other challenges,
risks and uncertainties. Consumers of vitamins, supplements, minerals and
other similar products may not purchase products from our site, which would
reduce our revenues and prevent us from becoming profitable.

 BentleyCapitalCorp.com May Need Additional Financing Which May Not Be
 Available, or Which May Dilute the Ownership Interests of Investors

  BentleyCapitalCorp.com's ultimate success will depend on its ability to
raise additional capital. No commitments to provide additional funds have been
made by management or other shareholders. BentleyCapitalCorp.com has not
investigated the availability, source or terms that might govern the
acquisition of additional financing. When additional capital is needed, there
is no assurance that funds will be available from any source or, if available,
that they can be obtained on terms acceptable to BentleyCapitalCorp.com. If
not available, BentleyCapitalCorp.com's operations would be severely limited,
and it would be unable to implement its business plan.

                                       8


Risks Related to the Securities Market

 BentleyCapitalCorp.com's Common Stock Has No Prior Market, and Prices May
 Decline After the Offering

  There is no public market for BentleyCapitalCorp.com's common stock and no
assurance can be given that a market will develop or that any shareholder will
be able to liquidate its investment without considerable delay, if at all. The
trading market price of BentleyCapitalCorp.com's common stock may decline
below the offering price. If a market should develop, the price may be highly
volatile. In addition, an active public market for BentleyCapitalCorp.com's
common stock may not develop or be sustained. Factors such as those discussed
in this "Risk Factors" section may have a significant impact on the market
price of BentleyCapitalCorp.com's securities. Owing to the low price of the
securities, many brokerage firms may not be willing to effect transactions in
the securities. Even if a purchaser finds a broker willing to effect a
transaction in BentleyCapitalCorp.com's common stock, the combination of
brokerage commissions, state transfer taxes, if any, and other selling costs
may exceed the selling price. Further, many lending institutions will not
permit the use of such securities as collateral for loans. Thus, a purchaser
may be unable to sell or otherwise realize the value invested in
BentleyCapitalCorp.com stock.

 Investors May Face Significant Restrictions on the Resale of
 BentleyCapitalCorp.com Stock Due to State Blue Sky Laws

  Because BentleyCapitalCorp.com's securities have not been registered for
resale under the blue sky laws of any state, the holders of such shares and
those persons desiring to purchase them in any trading market that may develop
in the future should be aware that there may be significant state blue sky law
restrictions on the ability of investors to sell and on purchasers to buy
BentleyCapitalCorp.com's securities. Each state has its own securities laws,
often called "blue sky laws", which limit sales of stock to a state's
residents unless the stock is registered in that state or qualifies for an
exemption from registration, and govern the reporting requirements for broker-
dealers and stock brokers doing business directly or indirectly in the state.
Before a security is sold in a state, there must be a registration in place to
cover the transaction, and the broker must be registered in that state, or
otherwise be exempt from registration. BentleyCapitalCorp.com does not know
whether its stock will be registered under the laws of any states. A
determination regarding registration will be made by the broker-dealers, if
any, who agree to serve as the market-makers for BentleyCapitalCorp.com's
stock.

  Accordingly, investors should consider the secondary market for
BentleyCapitalCorp.com's securities to be a limited one. Investors may be
unable to resell their stock, or may be unable to resell it without the
significant expense of state registration or qualification.

 Investors May Face Significant Restrictions on the Resale of
 BentleyCapitalCorp.com Stock Due to Federal Penny Stock Regulations

  In addition, the Securities and Exchange Commission has adopted a number of
rules to regulate "penny stocks." Such rules include Rules 3a51-1, 15g-1, 15g-
2, 15g-3, 15g-4, 15g-5, 15g-6 and 15g-7 under the Securities and Exchange Act
of 1934, as amended. Because BentleyCapitalCorp.com's securities may
constitute "penny stock" within the meaning of the rules, the rules would
apply to BentleyCapitalCorp.com and its securities. The rules may further
affect the ability of owners of BentleyCapitalCorp.com's shares to sell their
securities in any market that may develop for them. There may be a limited
market for penny stocks, due to the regulatory burdens on broker-dealers. The
market among dealers may not be active. Investors in penny stock often are
unable to sell stock back to the dealer that sold them the stock. The mark ups
or commissions charged by the broker-dealers may be greater than any profit a
seller may make. Because of large dealer spreads, investors may be unable to
sell the stock immediately back to the dealer at the same price the dealer
sold the stock to the investor. In some cases, the stock may fall quickly in
value. Investors may be unable to reap any profit from any sale of the stock,
if they can sell it at all.

                                       9


  Shareholders should be aware that, according to the Securities and Exchange
Commission Release No. 34-29093, the market for penny stocks has suffered in
recent years from patterns of fraud and abuse. Such patterns include:

  .  control of the market for the security by one or a few broker-dealers
     that are often related to the promoter or issuer;

  .  manipulation of prices through prearranged matching of purchases and
     sales and false and misleading press releases;

  .  "boiler room" practices involving high pressure sales tactics and
     unrealistic price projections by inexperienced sales persons;

  .  excessive and undisclosed bid-ask differentials and markups by selling
     broker-dealers; and

  .  the wholesale dumping of the same securities by promoters and broker-
     dealers after prices have been manipulated to a desired level, along
     with the inevitable collapse of those prices with consequent investor
     losses.

                                USE OF PROCEEDS

  The net proceeds to BentleyCapitalCorp.com from the sale of the 500,000
shares of common stock offered by BentleyCapitalCorp.com hereby at an assumed
initial public offering price of $.01 per share are estimated to be $5,000.
BentleyCapitalCorp.com expects to use the net proceeds for organizational
purposes, to conduct a search for employees, and to determine the feasibility
of selling Vitamineralherb.com products to specific markets.

  BentleyCapitalCorp.com continually evaluates other business opportunities
that may be available to it, whether in the form of assets acquisitions or
business combinations. BentleyCapitalCorp.com may use a portion of the
proceeds for these purposes. BentleyCapitalCorp.com is not currently a party
to any contracts, letters of intent, commitments or agreements and is not
currently engaged in active negotiations with respect to any acquisitions.

  BentleyCapitalCorp.com has not yet determined the amount of net proceeds to
be used specifically for any of the foregoing purposes. Accordingly,
BentleyCapitalCorp.com's management will have significant flexibility in
applying the net proceeds of the offering.

                        DETERMINATION OF OFFERING PRICE

  BentleyCapitalCorp.com arbitrarily determined the price of the Units in this
Offering. The offering price is not an indication of and is not based upon the
actual value of BentleyCapitalCorp.com. It bears no relationship to the book
value, assets or earnings of BentleyCapitalCorp.com or any other recognized
criteria of value. The offering price should not be regarded as an indicator
of the future market price of the securities.

                           SELLING SECURITY HOLDERS

  There are no selling security holders.

                                      10


                             PLAN OF DISTRIBUTION

  BentleyCapitalCorp.com will sell a maximum of 500,000 shares of its common
stock to the public on a "best efforts" basis. There can be no assurance that
any of these shares will be sold. The gross proceeds to BentleyCapitalCorp.com
will be $5,000 if all the shares offered are sold. No commissions or other
fees will be paid, directly or indirectly, by BentleyCapitalCorp.com, or any
of its principals, to any person or firm in connection with solicitation of
sales of the shares. No public market currently exists for shares of
BentleyCapitalCorp.com's common stock. BentleyCapitalCorp.com intends to apply
to have its shares traded on the OTC bulletin board under the symbol "BCCC".

                               LEGAL PROCEEDINGS

  BentleyCapitalCorp.com is not a party to any pending legal proceeding or
litigation and none of its property is the subject of a pending legal
proceeding. Further, the officer and director knows of no legal proceedings
against BentleyCapitalCorp.com or its property contemplated by any
governmental authority.

         DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

  The following table sets forth the name, age and position of each director
and executive officer of BentleyCapitalCorp.com:



     Name                          Age                 Position
     ----                          ---                 --------
                                 
     Michael Kirsh................  46 President, Secretary, Treasurer, Director


  In March, 2000, Mr. Kirsh was elected as the sole officer and director of
BentleyCapitalCorp.com by the current shareholders, of whom he is majority
stockholder. He will serve until the first annual meeting of
BentleyCapitalCorp.com's shareholders and his successors are elected and
qualified. Thereafter, directors will be elected for one-year terms at the
annual shareholders' meeting. Officers will hold their positions at the
pleasure of the board of directors, absent any employment agreement.

  During the past five years, Mr. Kirsh has worked with a group of independent
investors that acquires private companies and conducts reverse takeovers. In a
reverse takeover, the shareholders of an acquired company generally end up
owning all or most of the resulting combined company. Before forming his
investment group, Mr. Kirsh had invested in both real estate and the stock
market. From approximately 1986 to 1992 Mr. Kirsh developed two dental
practices in Vancouver, British Columbia, Canada, which he sold in 1992 before
forming his investment group.

  Mr. Kirsh is the sole shareholder, officer, and director of Ucellit.com
Inc., a company with a Vitamineralherb.com license for the territory of
Ontario, Canada. Ucellit.com also plans to register its securities pursuant to
a Form SB-2 registration statement. Mr. Kirsh is also the sole shareholder,
officer and director of Gentry Resources, Inc., and Growtex Inc., both of
which filed with the Securities and Exchange Commission on March 10, 2000,
Forms 10-SB pursuant to the Securities Exchange Act of 1934.

  Mr. Kirsh is also a director of Mezuma Mining, which is traded on the
Alberta Stock Exchange. Mezuma Mining has currently raised approximately
$250,000.00 Canadian and is looking for a company to acquire.

                                      11


        SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

  The following table sets forth, as of March 28, 2000,
BentleyCapitalCorp.com's outstanding common stock owned of record or
beneficially by each Executive Officer and Director and by each person who
owned of record, or was known by BentleyCapitalCorp.com to own beneficially,
more than 5% of its common stock, and the shareholdings of all Executive
Officers and Directors as a group. Each person has sole voting and investment
power with respect to the shares shown.



                                                       Shares   Percentage of
     Name                                               Owned   Shares Owned
     ----                                             --------- -------------
                                                          
     Michael Kirsh..................................  1,500,000      100%
      President, Secretary, Treasurer, and Director
       5076 Angus Drive
       Vancouver, BC Canada V6M 3M5
     All Executive Officers and Directors as a Group
      (1 Individual)................................  1,500,000      100%


                           DESCRIPTION OF SECURITIES

  The following description of BentleyCapitalCorp.com's capital stock is a
summary of the material terms of its capital stock. This summary is subject to
and qualified in its entirety by BentleyCapitalCorp.com's articles of
incorporation and bylaws, which are included as exhibits to the registration
statement of which this prospectus forms a part, and by the applicable
provisions of Washington law.

  The authorized capital stock of BentleyCapitalCorp.com consists of
120,000,000 shares: 100,000,000 shares of Common Stock having a par value of
$0.0001 per share and 20,000,000 shares of Preferred Stock having a par value
of $0.0001 per share. The articles of incorporation do not permit cumulative
voting for the election of directors, and shareholders do not have any
preemptive rights to purchase shares in any future issuance of
BentleyCapitalCorp.com's common stock.

  The holders of shares of common stock of BentleyCapitalCorp.com do not have
cumulative voting rights in connection with the election of the Board of
Directors, which means that the holders of more than 50% of such outstanding
shares, voting for the election of directors, can elect all of the directors
to be elected, if they so choose, and, in such event, the holders of the
remaining shares will not be able to elect any of BentleyCapitalCorp.com's
directors.

  The holders of shares of common stock are entitled to dividends, out of
funds legally available therefor, when and as declared by the Board of
Directors. The Board of Directors has never declared a dividend and does not
anticipate declaring a dividend in the future. Each outstanding share of
common stock entitles the holder thereof to one vote per share on all matters.
The holders of the shares of common stock have no preemptive or subscription
rights. In the event of liquidation, dissolution or winding up of the affairs
of BentleyCapitalCorp.com, holders are entitled to receive, ratably, the net
assets of BentleyCapitalCorp.com available to shareholders after payment of
all creditors.

  All of the issued and outstanding shares of common stock are duly
authorized, validly issued, fully paid, and non-assessable. To the extent that
additional shares of BentleyCapitalCorp.com's common stock are issued, the
relative interests of existing shareholders may be diluted.

                     INTEREST OF NAMED EXPERTS AND COUNSEL

  Neither Elliott Tulk Pryce Anderson nor Ogden Murphy Wallace, PLLC was
employed on a contingent basis in connection with the registration or offering
of BentleyCapitalCorp.com's common stock.

                                      12


                     DISCLOSURE OF COMMISSION POSITION ON
                INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

  BentleyCapitalCorp.com's articles of incorporation, filed herewith as
Exhibit 3.1, provide that it will indemnify its officers and directors to the
full extent permitted by Washington state law. BentleyCapitalCorp.com's
bylaws, filed herewith as Exhibit 3.2, provide that it will indemnify and hold
harmless each person who was, is or is threatened to be made a party to or is
otherwise involved in any threatened proceedings by reason of the fact that he
or she is or was a director or officer of BentleyCapitalCorp.com or is or was
serving at the request of BentleyCapitalCorp.com as a director, officer,
partner, trustee, employee, or agent of another entity, against all losses,
claims, damages, liabilities and expenses actually and reasonably incurred or
suffered in connection with such proceeding.

  Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of
BentleyCapitalCorp.com pursuant to the forgoing provisions or otherwise,
BentleyCapitalCorp.com has been advised that, in the opinion of the Securities
and Exchange Commission, such indemnification is against public policy as
expressed in that Act and is, therefore, unenforceable.

                            DESCRIPTION OF BUSINESS

 General

  BentleyCapitalCorp.com was incorporated under the laws of the State of
Washington on March 14, 2000, and is in its early developmental and
promotional stages. To date, BentleyCapitalCorp.com's only activities have
been organizational, directed at acquiring its principal asset, raising its
initial capital and developing its business plan. BentleyCapitalCorp.com has
not commenced commercial operations. BentleyCapitalCorp.com has no full time
employees and owns no real estate. BentleyCapitalCorp.com's business plan is
to determine the feasibility of selling Vitamineralherb.com products to
specific markets. Should BentleyCapitalCorp.com determine that the plan is
feasible, it intends to market high-quality, low-cost vitamins, minerals,
nutritional supplements, and other health and fitness products to medical
professionals, alternative health professionals, martial arts studios and
instructors, sports and fitness trainers, other health and fitness
professionals, school and other fund raising programs and other similar types
of customers via the Internet for sale to their clients.

 Acquisition of The License

  On March 20, 2000, BentleyCapitalCorp.com's sole shareholder, Michael Kirsh,
in return for 1,500,000 shares of BentleyCapitalCorp.com's common stock and a
promissory note for $28,000, transferred to BentleyCapitalCorp.com his rights
under that certain License Agreement with Vitamineralherb.com, filed herewith
as Exhibit 10.1. The License Agreement grants an exclusive right to distribute
Vitamineralherb.com products to health and fitness professionals in British
Columbia via the Internet. Mr. Kirsh acquired the license under the terms of a
settlement agreement by and between Mr. Kirsh, Gentry Resources, Inc., a
company in which he is the sole shareholder, officer and director, and
Mortenson & Associates, an affiliate of Vitamineralherb.com. Mortenson &
Associates had granted Gentry Resources a license to distribute and produce an
oxygen enriched water product, called "Biocatalyst," for remediation of sewage
and waste water in septic tanks and waste water treatment facilities.
Mortenson & Associates acquired its right to sublicense Biocatalyst to Gentry
Resources from NW Technologies Inc. As a result of a legal dispute between
Mortenson & Associates' principal and NW Technologies, Mortenson & Associates
was unable to fulfill its obligations to Gentry Resources under the license.
Under the terms of the settlement agreement, Vitamineralherb.com, an affiliate
of Mortenson & Associates, granted to Kirsh the license to distribute
Vitamineralherb.com products in part for his agreement not to pursue his
individual claims against Mortenson & Associates.

                                      13


 The License

  BentleyCapitalCorp.com has a three year license, filed herewith as Exhibit
10.1, to market and sell vitamins, minerals, nutritional supplements, and
other health and fitness products to medical professionals, alternative health
professionals, martial arts studios and instructors, sports and fitness
trainers, other health and fitness professionals, school and other fund
raising programs and other similar types of customers via the Internet for
sale to their clients. The license will be automatically renewed unless
BentleyCapitalCorp.com or Vitamineralherb.com gives the other notice of its
intent not to renew.

  As a licensee of Vitamineralherb.com, BentleyCapitalCorp.com eliminates the
need to develop products, store inventory, build and maintain a website,
establish banking liaisons, and develop a fulfillment system, thereby enabling
BentleyCapitalCorp.com to focus strictly on marketing and sales.
BentleyCapitalCorp.com plans to target health and fitness professionals in
British Columbia who wish to offer health and fitness products to their
customers.

  BentleyCapitalCorp.com (and its customers) will have access to all products
offered on the Vitamineralherb website, as well as the ability to order
custom-formulated and custom-labeled products. Vitamineralherb.com sets the
price for products based on the manufacturer's price, plus a mark up which
provides a 10% commission to Vitamineralherb.com and a profit for
BentleyCapitalCorp.com. Three different labeling options are available to
customers: First, products may be ordered with the manufacturer's standard
label with no customization. Second, the fitness or health professional may
customize the labels by adding its name, address, and phone number to the
standard label. In most cases, these labels would be a standardized label with
product information and a place on the label for the wording "Distributed by."
This gives these health and fitness professionals a competitive edge. Third,
labels may be completely customized for the health or fitness professional.

  When a fitness or health professional becomes a client,
BentleyCapitalCorp.com's salesperson will show the client how to access the
Vitamineralherb website. The client is assigned an identification number that
identifies it by territory, salesperson, and business name, address, and other
pertinent information. The health or fitness professional may then order the
products it desires directly through the Vitamineralherb.com website, paying
for the purchase with a credit card, electronic check ("e-check"), or debit
card. All products are shipped by the manufacturer directly to the
professional or its clients.

  The website is maintained by Vitamineralherb.com, and each licensee pays an
annual website maintenance fee of $500. All financial transactions are handled
by Vitamineralherb.com's Internet clearing bank. The Vitamineralherb webmaster
downloads e-mail orders several times a day, checks with clearing bank for
payment and then submits the product order and electronic payment to
International Formulation and Manufacturing. Vitamineralherb.com then forwards
the money due BentleyCapitalCorp.com via electronic funds transfer.
Vitamineralherb's software tracks all sales through the customer's
identification number, and at month end, e-mails to BentleyCapitalCorp.com and
customer a detailed report including sales commissions. Vitamineralherb has
indicated that it will use e-commerce advertising such as banner ads on major
servers and websites, as well as trying to insure that all major search
engines pick Vitamineralherb.com first. Sales originating from the website to
customers located in British Columbia will automatically be assigned to
BentleyCapitalCorp.com.

 Background on the Manufacturer and Distributor

  On June 9, 1999, Vitamineralherb.com entered into a manufacturing agreement
with International Formulation and Manufacturing Inc. a nutraceuticals
manufacturing firm, located in San Diego, California, USA. International
Formulation and Manufacturing is a contract manufacturer of vitamin, mineral,
nutritional supplement, and alternative health products for various marketing
organizations; International Formulation and Manufacturing does no retail
marketing. In addition to a line of standard products, International
Formulation and Manufacturing is able to manufacture custom blended products
for customers. International Formulation and Manufacturing also has the
capability to supply privately labeled products for BentleyCapitalCorp.com's
customers at a minimal added cost.

                                      14


 Industry Background

  Growth of the Internet and electronic commerce. The Internet has become an
increasingly significant medium for communication, information and commerce.
According to NUA Internet Surveys, as of February 2000, there were
approximately 275.5 million Internet users worldwide. At the IDC Internet
Executive Forum held on September 28-29, 1999, IDC stated that in 1999 US $109
billion in purchases were impacted by the Internet. IDC's vice president, Sean
Kaldor, indicated that figure is expected to increase more than ten-fold over
the next five years to US $1.3 trillion in 2003, with $842 million completed
directly over the Web. BentleyCapitalCorp.com believes that this dramatic
growth presents significant opportunities for online retailers.

  The vitamin, supplement, mineral and alternative health product market. In
recent years, a growing awareness of vitamins, herbs, and other dietary
supplements by the general public has created a whole new segment in the field
of medicine and health care products. According to Jupiter Communications,
online sales of such products are expected to be US $434 million in the year
2003, up from $1 million in 1998. BentleyCapitalCorp.com believes that several
factors are driving this growth, including a rapidly growing segment of the
population that is concerned with aging and disease, a growing interest in
preventative health care, favorable consumer attitudes toward alternative
health products and a favorable regulatory statute, the Dietary Supplement
Health and Education Act of 1994.

 Competition

  The electronic commerce industry is new, rapidly evolving and intensely
competitive, and BentleyCapitalCorp.com expects competition to intensify in
the future. Barriers to entry are minimal and current and new competitors can
launch sites at a relatively low cost. In addition, the vitamin, supplement,
mineral and alternative health product market is very competitive and highly
fragmented, with no clear dominant leader and increasing public and commercial
attention.

  BentleyCapitalCorp.com's competitors can be divided into several groups
including:

  .  traditional vitamins, supplements, minerals and alternative health
     products retailers;

  .  the online retail initiatives of several traditional vitamins,
     supplements, minerals and alternative health products retailers;

  .  online retailers of pharmaceutical and other health-related products
     that also carry vitamins, supplements, minerals and alternative health
     products;

  .  independent online retailers specializing in vitamins, supplements,
     minerals and alternative health products;

  .  mail-order and catalog retailers of vitamins, supplements, minerals and
     alternative health products, some of which have already developed online
     retail outlets; and

  .  direct sales organizations, retail drugstore chains, health food store
     merchants, mass market retail chains and various manufacturers of
     alternative health products.

  Many of BentleyCapitalCorp.com's potential competitors have longer operating
histories, larger customer or user bases, greater brand recognition and
significantly greater financial, marketing and other resources than
BentleyCapitalCorp.com has. In addition, an online retailer may be acquired
by, receive investments from, or enter into other commercial relationships
with, larger, well-established and well-financed companies as use of the
Internet and other electronic services increases. Competitors have and may
continue to adopt aggressive pricing or inventory availability policies and
devote substantially more resources to website and systems development than
BentleyCapitalCorp.com does. Increased competition may result in reduced
operating margins and loss of market share.

  BentleyCapitalCorp.com believes that the principal competitive factors in
its market are:

  .  ability to attract and retain customers;

                                      15


  .  breadth of product selection;

  .  product pricing;

  .  ability to customize products and labeling;

  .  quality and responsiveness of customer service.

  BentleyCapitalCorp.com believes that it can compete favorably on these
factors. However, BentleyCapitalCorp.com will have no control over how
successful its competitors are in addressing these factors. In addition, with
little difficulty, BentleyCapitalCorp.com's online competitors can duplicate
many of the products or services offered on the Vitamineralherb.com site.

  BentleyCapitalCorp.com believes that traditional retailers of vitamins,
supplements, minerals and other alternative health products face several
challenges in succeeding:

  .  Lack of convenience and personalized service. Traditional retailers have
     limited store hours and locations. Traditional retailers are also unable
     to provide consumers with product advice tailored to their particular
     situation.

  .  Limited product assortment. The capital and real estate intensive nature
     of store-based retailers limit the product selection that can be
     economically offered in each store location.

  .  Lack of Customer Loyalty. Although the larger traditional retailers
     often attract customers, many of these customers are only one-time
     users. People are often attractive to the name brands, but find the
     products too expensive. It is understood that these are quality products
     and have value, but the multilevel structure of marketing often employed
     by large retailers mandate high prices.

  As a result of the foregoing limitations, BentleyCapitalCorp.com believes
there is significant unmet demand for an alternative shopping channel that can
provide consumers of vitamins, supplements, minerals and other alternative
health products with a broad array of products and a convenient and private
shopping experience.

  BentleyCapitalCorp.com hopes to attract and retain consumers through the
following key attributes of its business:

  .  Broad Expandable Product Assortment. BentleyCapitalCorp.com's product
     selection is substantially larger than that offered by store-based
     retailers.

  .  Low Product Prices. Product prices can be kept low due to volume
     purchases through BentleyCapitalCorp.com's affiliation with
     Vitamineralherb.com and other licensees. Product prices will also be
     lower due to BentleyCapitalCorp.com's lack of need of inventory and
     warehouse space. All products are shipped from International Formulation
     and Manufacturing's inventory.

  .  Accessibility to Customized Products. At minimal cost, health and
     fitness practitioners may offer their customers customized products.

  .  Access to Personalized Programs. Health or fitness professional can
     tailor vitamin and dietary supplement regimes to their clients.

 Regulatory Environment

  The manufacturing, processing, formulating, packaging, labeling and
advertising of the products BentleyCapitalCorp.com sells in Canada are or may
be subject to regulation by Health Canada which administers the Food and Drugs
Act along with relevant regulation thereto. Regulated products include herbal
remedies, natural health remedies, functional foods and nutraceuticals. Health
Canada regulates the formulation, manufacture, labeling and distribution of
foods, including dietary supplements, cosmetics and over-the-counter or
homeopathic drugs. Under the Food and Drugs Act, a variety of enforcement
actions are available to Health Canada against marketers of unapproved drugs
or "adulterated" or "misbranded" products. The remedies

                                      16


available to Health Canada include: criminal prosecution; an injunction to
stop the sale of a company's products; seizure of products; adverse publicity;
and "voluntary" recalls and labeling changes.

  The Consumer Packaging and Labeling Act, as administered by Industry Canada,
requires that certain information labeling be presented in a prescribed manner
on all foods, drugs, dietary supplements and cosmetics. A product may be
deemed an unapproved drug and "misbranded" if it bears improper claims or
improper labeling.

  The manufacturing, processing, formulating, packaging, labeling and
advertising of the products BentleyCapitalCorp.com sells may also be subject
to regulation by one or more U.S. federal agencies, including the Food and
Drug Administration, the Federal Trade Commission, the United States
Department of Agriculture and the Environmental Protection Agency. These
activities also may be regulated by various agencies of the states, localities
and foreign countries in which consumers reside.

  The Food and Drug Administration, in particular, regulates the formulation,
manufacture, labeling and distribution of foods, including dietary
supplements, cosmetics and over-the- counter or homeopathic drugs. Under the
Federal Food, Drug, and Cosmetic Act, the Food and Drug Administration may
undertake enforcement actions against companies marketing unapproved drugs, or
"adulterated" or "misbranded" products. The remedies available to the Food and
Drug Administration include: criminal prosecution; an injunction to stop the
sale of a company's products; seizure of products; adverse publicity; and
"voluntary" recalls and labeling changes.

  Food and Drug Administration regulations require that certain informational
labeling be presented in a prescribed manner on all foods, drugs, dietary
supplements and cosmetics. Specifically, the Food, Drug, and Cosmetic Act
requires that food, including dietary supplements, drugs and cosmetics, not be
"misbranded." A product may be deemed an unapproved drug and "misbranded" if
it bears improper claims or improper labeling. The Food and Drug
Administration has indicated that promotional statements made about dietary
supplements on a company's website may constitute "labeling" for purposes of
compliance with the provisions of the Food, Drug, and Cosmetic Act. A
manufacturer or distributor of dietary supplements must notify the Food and
Drug Administration when it markets a product with labeling claims that the
product has an effect on the structure or function of the body. Noncompliance
with the Food, Drug, and Cosmetic Act, and recently enacted amendments to that
Act discussed below, could result in enforcement action by the Food and Drug
Administration.

  The Food, Drug, and Cosmetic Act has been amended several times with respect
to dietary supplements, most recently by the Nutrition Labeling and Education
Act of 1990 and the Dietary Supplement Health and Education Act of 1994. The
Dietary Supplement Health and Education Act created a new statutory framework
governing the definition, regulation and labeling of dietary supplements. With
respect to definition, the Dietary Supplement Health and Education Act created
a new class of dietary supplements, consisting of vitamins, minerals, herbs,
amino acids and other dietary substances for human use to supplement the diet,
as well as concentrates, metabolites, extracts or combinations of such dietary
ingredients. Generally, under the Dietary Supplement Health and Education Act,
dietary ingredients that were on the market before October 15, 1994 may be
sold without Food and Drug Administration pre-approval and without notifying
the Food and Drug Administration. In contrast, a new dietary ingredient, i.e.,
one not on the market before October 15, 1994, requires proof that it has been
used as an article of food without being chemically altered or evidence of a
history of use or other evidence of safety establishing that it is reasonably
expected to be safe. Retailers, in addition to dietary supplement
manufacturers, are responsible for ensuring that the products they market for
sale comply with these regulations. Noncompliance could result in enforcement
action by the Food and Drug Administration, an injunction prohibiting the sale
of products deemed to be noncompliant, the seizure of such products and
criminal prosecution.

  The Food and Drug Administration has indicated that claims or statements
made on a company's website about dietary supplements may constitute
"labeling" and thus be subject to regulation by the Food and Drug
Administration. With respect to labeling, the Dietary Supplement Health and
Education Act amends, for dietary supplements, the Nutrition Labeling and
Education Act by providing that "statements of nutritional support,"

                                      17


also referred to as "structure/function claims," may be used in dietary
supplement labeling without Food and Drug Administration pre-approval,
provided certain requirements are met. These statements may describe how
particular dietary ingredients affect the structure or function of the body,
or the mechanism of action by which a dietary ingredient may affect body
structure or function, but may not state a drug claim, i.e., a claim that a
dietary supplement will diagnose, mitigate, treat, cure or prevent a disease.
A company making a "statement of nutritional support" must possess
substantiating evidence for the statement, disclose on the label that the Food
and Drug Administration has not reviewed the statement and that the product is
not intended for use for a disease and notify the Food and Drug Administration
of the statement within 30 days after its initial use. It is possible that the
statements presented in connection with product descriptions on
BentleyCapitalCorp.com's site may be determined by the Food and Drug
Administration to be drug claims rather than acceptable statements of
nutritional support. In addition, some of BentleyCapitalCorp.com's suppliers
may incorporate objectionable statements directly in their product names or on
their products' labels, or otherwise fail to comply with applicable
manufacturing, labeling and registration requirements for over-the-counter or
homeopathic drugs or dietary supplements. As a result, Vitamineralherb.com may
have to remove objectionable statements or products from its site or modify
these statements, or product names or labels, in order to comply with Food and
Drug Administration regulations. Such changes could interfere with
BentleyCapitalCorp.com's marketing of products and could cause us to incur
significant additional expenses.

  In addition, the Dietary Supplement Health and Education Act allows the
dissemination of "third party literature" in connection with the sale of
dietary supplements to consumers at retail if the publication meets statutory
requirements. Under the Dietary Supplement Health and Education Act, "third
party literature" may be distributed if, among other things, it is not false
or misleading, no particular manufacturer or brand of dietary supplement is
promoted, a balanced view of available scientific information on the subject
matter is presented and there is physical separation from dietary supplements
in stores. The extent to which this provision may be used by online retailers
is not yet clear, and BentleyCapitalCorp.com cannot assure you that all pieces
of "third party literature" that may be disseminated in connection with the
products BentleyCapitalCorp.com offers for sale will be determined to be
lawful by the Food and Drug Administration. Any such failure could render the
involved product an unapproved drug or a "misbranded" product, potentially
subjecting us to enforcement action by the Food and Drug Administration, and
could require the removal of the noncompliant literature from
Vitamineralherb.com's website or the modification of BentleyCapitalCorp.com's
selling methods, interfering with BentleyCapitalCorp.com's continued marketing
of that product and causing us to incur significant additional expenses. Given
the fact that the Dietary Supplement Health and Education Act was enacted only
five years ago, the Food and Drug Administration's regulatory policy and
enforcement positions on certain aspects of the new law are still evolving.
Moreover, ongoing and future litigation between dietary supplement companies
and the Food and Drug Administration will likely further refine the legal
interpretations of the Dietary Supplement Health and Education Act. As a
result, the regulatory status of certain types of dietary supplement products,
as well as the nature and extent of permissible claims will remain unclear for
the foreseeable future. Two areas in particular that pose potential regulatory
risk are the limits on claims implying some benefit or relationship with a
disease or related condition and the application of the physical separation
requirement for "third party literature" as applied to Internet sales.

  In addition to the regulatory scheme under the Food, Drug and Cosmetic Act,
the advertising and promotion of dietary supplements, foods, over-the-counter
drugs and cosmetics is subject to scrutiny by the Federal Trade Commission.
The Federal Trade Commission Act prohibits "unfair or deceptive" advertising
or marketing practices, and the Federal Trade Commission has pursued numerous
food and dietary supplement manufacturers and retailers for deceptive
advertising or failure to substantiate promotional claims, including, in many
instances, claims made via the Internet. The Federal Trade Commission has the
power to seek administrative or judicial relief prohibiting a wide variety of
claims, to enjoin future advertising, to seek redress or restitution payments
and to seek a consent order and seek monetary penalties for the violation of a
consent order. In general, existing laws and regulations apply fully to
transactions and other activity on the Internet. The Federal Trade Commission
is in the process of reviewing its policies regarding the applicability of its
rules and its consumer protection guides to the Internet and other electronic
media. The Federal Trade Commission has already undertaken a new monitoring
and enforcement initiative, "Operation Cure-All," targeting allegedly bogus
health claims for

                                      18


products and treatments offered for sale on the Internet. Many states impose
their own labeling or safety requirements that differ from or add to existing
federal requirements.

  BentleyCapitalCorp.com cannot predict the nature of any future Canadian or
U.S. laws, regulations, interpretations or applications, nor can it determine
what effect additional governmental regulations or administrative orders, when
and if promulgated, would have on its business in the future. Although the
regulation of dietary supplements is less restrictive than that of drugs and
food additives, BentleyCapitalCorp.com cannot assure you that the current
statutory scheme and regulations applicable to dietary supplements will remain
less restrictive. Further, BentleyCapitalCorp.com cannot assure you that,
under existing laws and regulations, or if more stringent statutes are
enacted, regulations are promulgated or enforcement policies are adopted, it
is or will be in compliance with these existing or new statutes, regulations
or enforcement policies without incurring material expenses or adjusting its
business strategy. Any laws, regulations, enforcement policies,
interpretations or applications applicable to BentleyCapitalCorp.com's
business could require the reformulation of certain products to meet new
standards, the recall or discontinuance of certain products not capable of
reformulation, additional record keeping, expanded documentation of the
properties of certain products, expanded or different labeling or scientific
substantiation.

  Regulation of the Internet. In general, existing laws and regulations apply
to transactions and other activity on the Internet; however, the precise
applicability of these laws and regulations to the Internet is sometimes
uncertain. The vast majority of such laws were adopted prior to the advent of
the Internet and, as a result, do not contemplate or address the unique issues
of the Internet or electronic commerce. Nevertheless, numerous federal and
state government agencies have already demonstrated significant activity in
promoting consumer protection and enforcing other regulatory and disclosure
statutes on the Internet. Additionally, due to the increasing use of the
Internet as a medium for commerce and communication, it is possible that new
laws and regulations may be enacted with respect to the Internet and
electronic commerce covering issues such as user privacy, freedom of
expression, advertising, pricing, content and quality of products and
services, taxation, intellectual property rights and information security. The
adoption of such laws or regulations and the applicability of existing laws
and regulations to the Internet may impair the growth of Internet use and
result in a decline in BentleyCapitalCorp.com's sales.

  A number of legislative proposals have been made at the federal, state and
local level, and by foreign governments, that would impose additional taxes on
the sale of goods and services over the Internet, and certain states have
taken measures to tax Internet-related activities. Although Congress recently
placed a three-year moratorium on new state and local taxes on Internet access
or on discriminatory taxes on electronic commerce, existing state or local
laws were expressly excepted from this moratorium. Further, once this
moratorium is lifted, some type of federal and/or state taxes may be imposed
upon Internet commerce. Such legislation or other attempts at regulating
commerce over the Internet may substantially impair the growth of commerce on
the Internet and, as a result, adversely affect BentleyCapitalCorp.com's
opportunity to derive financial benefit from such activities.

 Employees

  BentleyCapitalCorp.com is a development stage company and currently has no
employees. BentleyCapitalCorp.com is currently managed by Michael Kirsh, its
sole officer and director. BentleyCapitalCorp.com looks to Mr. Kirsh for his
entrepreneurial skills and talents. For a complete discussion of Mr. Kirsh's
experience, please see "Directors and Executive Officers." Management plans to
use consultants, attorneys and accountants as necessary and does not plan to
engage any full-time employees in the near future. BentleyCapitalCorp.com may
hire marketing employees based on the projected size of the market and the
compensation necessary to retain qualified sales employees. A portion of any
employee compensation likely would include the right to acquire stock in
BentleyCapitalCorp.com, which would dilute the ownership interest of holders
of existing shares of its common stock.

                                      19


 Available Information and Reports to Securities Holders

  BentleyCapitalCorp.com has filed with the Securities and Exchange Commission
a registration statement on Form SB-2 with respect to the common stock offered
by this prospectus. This prospectus, which constitutes a part of the
registration statement, does not contain all of the information set forth in
the registration statement or the exhibits and schedules which are part of the
registration statement. For further information with respect to
BentleyCapitalCorp.com and its common stock, see the registration statement
and the exhibits and schedules thereto. Any document BentleyCapitalCorp.com
files may be read and copied at the Commission's Public Reference Room located
at 450 Fifth Street N.W., Washington D.C. 20549, and the public reference
rooms in New York, New York, and Chicago, Illinois. Please call the Commission
at 1-800-SEC-0330 for further information about the public reference rooms.
BentleyCapitalCorp.com's filings with the Commission are also available to the
public from the Commission's website at http://www.sec.gov.

  Upon completion of this offering, BentleyCapitalCorp.com will become subject
to the information and periodic reporting requirements of the Securities
Exchange Act and, accordingly, will file periodic reports, proxy statements
and other information with the Commission. Such periodic reports, proxy
statements and other information will be available for inspection and copying
at the Commission's public reference rooms, and the website of the Commission
referred to above.

           MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

  The following discussion and analysis of BentleyCapitalCorp.com's financial
condition and results of operations should be read in conjunction with the
Financial Statements and accompanying notes and the other financial
information appearing elsewhere in this Prospectus.

  This prospectus contains forward-looking statements, the accuracy of which
involve risks and uncertainties. Words such as "anticipates," "believes,"
"plans," "expects," "future," "intends" and similar expressions are used to
identify forward-looking statements. This prospectus also contains forward-
looking statements attributed to certain third parties relating to their
estimates regarding the potential markets for Vitamineralherb products.
Prospective investors should not place undue reliance on these forward-looking
statements, which apply only as of the date of this prospectus.
BentleyCapitalCorp.com's actual results could differ materially from those
anticipated in these forward-looking statements for many reasons, including
the risks faced by BentleyCapitalCorp.com described in "Risk Factors" and
elsewhere in this prospectus. The following discussion and analysis should be
read in conjunction with BentleyCapitalCorp.com's Financial Statements and
Notes thereto and other financial information included elsewhere in this
prospectus.

 Results of Operations

  During the period from March 14, 2000 through March 31, 2000,
BentleyCapitalCorp.com has engaged in no significant operations other than
organizational activities, acquisition of the rights to market Vitamineralherb
and preparation for registration of its securities under the Securities Act of
1933, as amended. No revenues were received by BentleyCapitalCorp.com during
this period.

  For the current fiscal year, BentleyCapitalCorp.com anticipates incurring a
loss as a result of organizational expenses, expenses associated with
registration under the Securities Act of 1933, and expenses associated with
setting up a company structure to begin implementing its business plan.
BentleyCapitalCorp.com anticipates that until these procedures are completed,
it will not generate revenues, and may continue to operate at a loss
thereafter, depending upon the performance of the business.

  BentleyCapitalCorp.com's business plan is to determine the feasibility of
marketing the Vitamineralherb products in various markets, and, if the
products prove to be in demand, begin marketing and selling Vitamineralherb
products.

                                      20


 Liquidity and Capital Resources

  BentleyCapitalCorp.com remains in the development stage and, since
inception, has experienced no significant change in liquidity or capital
resources or shareholders' equity. Consequently, BentleyCapitalCorp.com's
balance sheet as of March 31, 2000, reflects total assets of $35,000, in the
form of a license and capitalized organizational costs. Organizational
expenses of $8,000 were paid for by the sole shareholder and expensed to
operations.

  BentleyCapitalCorp.com expects to carry out its plan of business as
discussed above. BentleyCapitalCorp.com has no immediate expenses, other than
the $8,000 of organizational expenses incurred and paid by the sole
shareholder on behalf of the company and $3,000 of additional expenses to be
incurred. Mr. Kirsh will serve in his capacity as sole officer and director of
BentleyCapitalCorp.com without compensation until a market is developed for
the Vitamineralherb products.

  In addition, BentleyCapitalCorp.com may engage in a combination with another
business. BentleyCapitalCorp.com cannot predict the extent to which its
liquidity and capital resources will be diminished prior to the consummation
of a business combination or whether its capital will be further depleted by
the operating losses (if any) of the business entity with which
BentleyCapitalCorp.com may eventually combine. BentleyCapitalCorp.com has
engaged in discussions concerning potential business combinations, but has not
entered into any agreement for such a combination.

  BentleyCapitalCorp.com will need additional capital to carry out its
business plan or to engage in a business combination. No commitments to
provide additional funds have been made by management or other shareholders.
Accordingly, there can be no assurance that any additional funds will be
available on terms acceptable to BentleyCapitalCorp.com or at all.
BentleyCapitalCorp.com has no commitments for capital expenditures.

                            DESCRIPTION OF PROPERTY

  BentleyCapitalCorp.com currently maintains limited office space, occupied by
Michael Kirsh, for which it pays no rent. Its address is 1177 West Hastings,
Suite 2110, Vancouver, British Columbia V6E 2K3, Canada and its phone number
is (604) 687-2199. BentleyCapitalCorp.com does not believe that it will need
to obtain additional office space at any time in the foreseeable future until
its business plan is more fully implemented.

                CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

  No director, executive officer or nominee for election as a director of
BentleyCapitalCorp.com, and no owner of five percent or more of
BentleyCapitalCorp.com's outstanding shares or any member of their immediate
family has entered into or proposed any transaction in which the amount
involved exceeds $60,000.

           MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

  No established public trading market exists for BentleyCapitalCorp.com's
securities. BentleyCapitalCorp.com has no common equity subject to outstanding
purchase options or warrants. BentleyCapitalCorp.com has no securities
convertible into its common equity. There is no common equity that could be
sold pursuant to Rule 144 under the Securities Act or that
BentleyCapitalCorp.com has agreed to register under the Securities Act for
sale by shareholders. Except for this offering, there is no common equity that
is being, or has been publicly proposed to be, publicly offered by
BentleyCapitalCorp.com.

  As of March 31, 2000, there were 1,500,000 shares of common stock
outstanding, held by 1 shareholder of record. Upon effectiveness of the
registration statement that includes this prospectus, all of
BentleyCapitalCorp.com's outstanding shares will be eligible for sale.

                                      21


  To date BentleyCapitalCorp.com has not paid any dividends on its common
stock and does not expect to declare or pay any dividends on its common stock
in the foreseeable future. Payment of any dividends will depend upon
BentleyCapitalCorp.com's future earnings, if any, its financial condition, and
other factors as deemed relevant by the Board of Directors.

                            EXECUTIVE COMPENSATION

  No officer or director has received any remuneration from
BentleyCapitalCorp.com. Although there is no current plan in existence, it is
possible that BentleyCapitalCorp.com will adopt a plan to pay or accrue
compensation to its officers and directors for services related to the
implementation of BentleyCapitalCorp.com's business plan.
BentleyCapitalCorp.com has no stock option, retirement, incentive, defined
benefit, actuarial, pension or profit-sharing programs for the benefit of
directors, officers or other employees, but the Board of Directors may
recommend adoption of one or more such programs in the future.
BentleyCapitalCorp.com has no employment contract or compensatory plan or
arrangement with any executive officer of BentleyCapitalCorp.com. The director
currently does not receive any cash compensation from BentleyCapitalCorp.com
for his service as a member of the board of directors. There is no
compensation committee, and no compensation policies have been adopted. See
"Certain Relationships and Related Transactions."

                                      22


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                              FINANCIAL STATEMENTS



                                                                            Page
                                                                            ----
                                                                         
   Independent Auditor's Report............................................ F-1


   Balance Sheet........................................................... F-2


   Statement of Operations................................................. F-3


   Statement of Cash Flows................................................. F-4


   Statement of Stockholders' Equity....................................... F-5


   Notes to the Financial Statements....................................... F-6



                        REPORT OF INDEPENDENT AUDITORS

To the Board of Directors
Bentleycapitalcorp.com Inc.
(A Development Stage Company)

  We have audited the accompanying balance sheet of Bentleycapitalcorp.com
Inc. (A Development Stage Company) as of March 31, 2000 and the related
statements of operations, stockholders' equity and cash flows for the period
from March 14, 2000 (Date of Inception) to March 31, 2000. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audit.

  We conducted our audit in accordance with U.S. generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audit provides a reasonable basis
for our opinion.

  In our opinion, the aforementioned financial statements present fairly, in
all material respects, the financial position of Bentleycapitalcorp.com Inc.
(A Development Stage Company), as of March 31, 2000, and the results of its
operations and its cash flows for the period from March 14, 2000 (Date of
Inception) to March 31, 2000, in conformity with U.S. generally accepted
accounting principles.

  The accompanying financial statements have been prepared assuming the
Company will continue as a going concern. As discussed in Note 1 to the
financial statements, the Company has not generated any revenues or conducted
any operations since inception. These factors raise substantial doubt about
the Company's ability to continue as a going concern. Management's plans in
regard to these matters are also discussed in Note 1. The financial statements
do not include any adjustments that might result from the outcome of this
uncertainty.

                                          /s/ Elliott Tulk Pryce Anderson

                                          CHARTERED ACCOUNTANTS

Vancouver, Canada
March 31, 2000

                                      F-1


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                                 BALANCE SHEET

                          (expressed in U.S. dollars)



                                                                     March 31,
                                                                       2000
                                                                     ---------
                                ASSETS
                                ------
                                                                  
   License (Notes 3 and 4)..........................................  $35,000
                                                                      =======

                 LIABILITIES AND STOCKHOLDERS' EQUITY
                 ------------------------------------
                                                                  
   Current Liabilities
     Note payable (Note 4)..........................................  $28,000
                                                                      -------
   Stockholders' Equity
     Common Stock, 100,000,000 common shares authorized with a par
      value of $.0001; 20,000,000 preferred shares with a par value
      of $.0001; 1,500,000 common shares issued and outstanding.....      150
     Additional Paid in Capital.....................................   14,850
     Preferred Stock, 20,000,000 preferred shares authorized with a
      par value of $.0001; none issued..............................      --
     Deficit Accumulated During the Development Stage...............   (8,000)
                                                                      -------
                                                                        7,000
                                                                      -------
                                                                      $35,000
                                                                      =======
   Contingent Liability (Note 1)
   Commitment (Note 3)




   (The accompanying notes are an integral part of the financial statements)

                                      F-2


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                            STATEMENT OF OPERATIONS

                          (expressed in U.S. dollars)




                                                             From March 14, 2000
                                                             (Date of Inception)
                                                              to March 31, 2000
                                                             -------------------
                                                          
     Revenue................................................       $   --
                                                                   -------
     Expenses
       Legal................................................         8,000
                                                                   -------
     Net Loss...............................................       $(8,000)
                                                                   =======




   (The accompanying notes are an integral part of the financial statements)

                                      F-3


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                            STATEMENT OF CASH FLOWS

                          (expressed in U.S. dollars)



                                                            From March 14, 2000
                                                            (Date of Inception)
                                                             to March 31, 2000
                                                            -------------------
                                                         
Cash Flows to Operating Activities:
  Net loss.................................................       $(8,000)
  Non-cash item............................................
    Note payable...........................................         8,000
                                                                  -------
Net Cash Used by Operating Activities......................           --
                                                                  -------
Change in cash.............................................           --
Cash--beginning of period..................................           --
                                                                  -------
Cash--end of period........................................           --
                                                                  =======
Non-Cash Financing Activities:
  A total of 1,500,000 shares were issued to a director at
   a fair market value of $0.01 per share for the
   acquisition of a License (Notes 3 and 5)................        15,000
  A note payable was issued to a director for the
   acquisition of a License (Notes 3 and 5)................        20,000
                                                                  -------
                                                                  $35,000
                                                                  =======
Supplemental Disclosures
  Interest paid............................................           --
  Income tax paid..........................................           --


                                      F-4


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                       STATEMENT OF STOCKHOLDERS' EQUITY
           From March 14, 2000 (Date of Inception) to March 31, 2000

                          (expressed in U.S. dollars)



                                                                      Deficit
                                                                    Accumulated
                                  Common Stock   Additional         During the
                                ----------------  Paid-in           Development
                                 Shares   Amount  Capital    Total     Stage
                                --------- ------ ---------- ------- -----------
                                                     
   Balance--March 14, 2000
    (Date of Inception).......        --  $ --    $   --    $   --    $   --
     Stock issued for a
      license at a fair market
      value of $0.01 share....  1,500,000   150    14,850    15,000       --
     Net loss for the period..        --    --        --        --     (8,000)
                                --------- -----   -------   -------   -------
   Balance--March 31, 2000....  1,500,000 $ 150   $14,850   $15,000   $(8,000)
                                ========= =====   =======   =======   =======




   (The accompanying notes are an integral part of the financial statements)

                                      F-5


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                       NOTES TO THE FINANCIAL STATEMENTS

                          (expressed in U.S. dollars)

1. DEVELOPMENT STAGE COMPANY

  BentleyCapitalCorp.com Inc. herein (the "Company") was incorporated in the
State of Washington, U.S.A. on March 14, 2000. The Company acquired a license
to market and distribute vitamins, minerals, nutritional supplements, and
other health and fitness products in which the grantor of the license offers
these products for sale from various suppliers on their Web Site.

  The Company is in the development stage.

  In a development stage company, management devotes most of its activities in
developing a market for its products. Planned principal activities have not
yet begun. The ability of the Company to emerge from the development stage
with respect to any planned principal business activity is dependent upon its
successful efforts to raise additional equity financing and/or attain
profitable operations. There is no guarantee that the Company will be able to
raise any equity financing or sell any of its products at a profit. There is
substantial doubt regarding the Company's ability to continue as a going
concern.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  (a)  Year end

    The Company's fiscal year end is December 31.

  (b)  License

    The cost to acquire a license is capitalized as incurred. These costs
  will be amortized on a straight-line basis over the next twelve months,
  commencing April 1, 2000.

  (c)  Cash and Cash Equivalents

    The Company considers all highly liquid instruments with a maturity of
  three months or less at the time of issuance to be cash equivalents.

  (d)  Use of Estimates

    The preparation of financial statements in conformity with generally
  accepted accounting principles requires management to make estimates and
  assumptions that affect the reported amounts of assets and liabilities and
  disclosure of contingent assets and liabilities at the date of the
  financial statements and the reported amounts of revenues and expenses
  during the periods. Actual results could differ from those estimates.

3. LICENSE

  The Company's only asset is a license to market vitamins, minerals,
nutritional supplements and other health and fitness products through the
Grantor's Web Site. The Company desires to market these products to medical
practitioners, alternative health professionals, martial arts studios and
instructors, sports and fitness trainers, other health and fitness
practitioners, school and other fund raising programs and other similar types
of customers in the Province of Ontario, Canada. The license was acquired on
March 20, 2000 for a term of three years. The Company must pay an annual fee
of $500 for maintenance of the Grantor's Web Site commencing on the
anniversary date. The Grantor of the license retains 50% of the profits.

  The Company paid total consideration of $35,000 for the license being
1,500,000 common shares and a note payable of $20,000.

                                      F-6


                          BENTLEYCAPITALCORP.COM INC.
                         (A Development Stage Company)

                NOTES TO THE FINANCIAL STATEMENTS--(Continued)

                          (expressed in U.S. dollars)


4. NOTE PAYABLE

  The note payable is unsecured, non-interest bearing and has no specific
terms of repayment.

5. RELATED PARTY TRANSACTION

  The License referred to in Note 3 was assigned to the Company by the sole
director and President of the Company for consideration of 1,500,000 shares
having a fair market value of $15,000 and a note payable of $20,000.

  The Grantor of the License is not related to the Company.

                 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
                    ON ACCOUNTING AND FINANCIAL DISCLOSURE

  None.

                                      F-7


                PART II--INFORMATION NOT REQUIRED IN PROSPECTUS

                   INDEMNIFICATION OF DIRECTORS AND OFFICERS

  BentleyCapitalCorp.com's Articles of Incorporation provide that it must
indemnify its directors and officers to the fullest extent permitted under
Washington law against all liabilities incurred by reason of the fact that the
person is or was a director or officer of BentleyCapitalCorp.com or a
fiduciary of an employee benefit plan, or is or was serving at the request of
BentleyCapitalCorp.com as a director or officer, or fiduciary of an employee
benefit plan, of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise.

  The effect of these provisions is potentially to indemnify
BentleyCapitalCorp.com's directors and officers from all costs and expenses of
liability incurred by them in connection with any action, suit or proceeding
in which they are involved by reason of their affiliation with
BentleyCapitalCorp.com. Pursuant to Washington law, a corporation may
indemnify a director, provided that such indemnity shall not apply on account
of: (a) acts or omissions of the director finally adjudged to be intentional
misconduct or a knowing violation of law; (b) unlawful distributions; or (c)
any transaction with respect to which it was finally adjudged that such
director personally received a benefit in money, property, or services to
which the director was not legally entitled.

  The bylaws of BentleyCapitalCorp.com, filed as Exhibit 3.2, provide that it
will indemnify its officers and directors for costs and expenses incurred in
connection with the defense of actions, suits, or proceedings against them on
account of their being or having been directors or officers of
BentleyCapitalCorp.com, absent a finding of negligence or misconduct in
office. BentleyCapitalCorp.com's Bylaws also permit it to maintain insurance
on behalf of its officers, directors, employees and agents against any
liability asserted against and incurred by that person whether or not
BentleyCapitalCorp.com has the power to indemnify such person against
liability for any of those acts.

                  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

  The securities are being registered for the account of selling shareholders,
and all of the following expenses will be borne by such shareholders. The
amounts set forth are estimates except for the SEC registration fee:



                                                                       Amount to
                                                                        be Paid
                                                                       ---------
                                                                    
       SEC registration fee...........................................  $    35
       Printing and engraving expenses................................      --
       Attorneys' fees and expenses...................................    8,000
       Accountants' fees and expenses.................................    1,500
       Transfer agent's and registrar's fees and expenses.............      500
       Miscellaneous..................................................      965
                                                                        -------
       Total..........................................................  $11,000
                                                                        =======


  The Registrant will bear all expenses shown above.

                    RECENT SALES OF UNREGISTERED SECURITIES

  Set forth below is information regarding the issuance and sales of
BentleyCapitalCorp.com's securities without registration since its formation.
No such sales involved the use of an underwriter and no commissions were paid
in connection with the sale of any securities.

On March 20, 2000, BentleyCapitalCorp.com issued 1,500,000 shares of common
stock to Michael Kirsh in compensation, along with a promissory note for
$28,000, for the license of Vitamineralherb.com rights. The issuance of the
shares was exempt from registration under Rule 506 of Regulation D, and
sections 3(b) and 4(2)

                                     II-1


of the Securities Act of 1933, as amended, due to Mr. Kirsh's status as the
founder and initial management of BentleyCapitalCorp.com, and his status as an
accredited investor, and the limited number of investors (one).

                                   EXHIBITS

  The following exhibits are filed as part of this Registration Statement:



           Exhibit
           Number  Description
           ------- -----------
                
             3.1   Articles of Incorporation
             3.2   Bylaws
             4.1   Specimen Stock Certificate
             4.2   Stock Subscription Agreement
             5.1   Opinion re: legality
            10.1   License Agreement
            10.2   Assignment of License Agreement
            10.3   Promissory Note
            23.1   Consent of Independent Auditors
            23.2   Consent of Counsel (see Exhibit 5.1)
            27.1   Financial Data Schedule


                                 UNDERTAKINGS

  The Registrant hereby undertakes that it will:

    (1) File, during any period in which it offers or sells securities, a
  post-effective amendment to this registration statement to:

        (i) Include any prospectus required by section 10(a)(3) of the
    Securities Act;

        (ii) Reflect in the prospectus any facts or events which,
    individually or together, represent a fundamental change in the
    information in the registration statement; and

      (iii) Include any additional or changed material information on the
    plan of distribution.

    (2) For determining liability under the Securities Act, treat each post-
  effective amendment as a new registration statement of the securities
  offered, and the Offering of the securities of the securities at that time
  to be the initial bona fide Offering.

    (3) File a post-effective amendment to remove from registration any of
  the securities that remain unsold at the end of the Offering.

    (4) Provide to the Underwriters at the closing specified in the
  underwriting agreement certificates in such denominations and registered in
  such names as required by the Underwriters to permit prompt delivery to
  each purchaser.

    (5) For determining any liability under the Securities Act, treat the
  information omitted from the form of prospectus filed as part of this
  registration statement in reliance upon Rule 430A and contained in a form
  of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or
  497(h) under the Securities Act as part of this registration statement as
  of the time the Commission declared it effective.

    (6) For determining any liability under the Securities Act, treat each
  post-effective amendment that contains a form of prospectus as a new
  registration statement for the securities offered in the registration
  statement, and the offering of the securities at that time as the initial
  bona fide Offering of those securities.

                                     II-2


  Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.

  In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.

                                     II-3


                                  SIGNATURES

  In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form SB-2 and authorized this
registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Vancouver, British Columbia, Canada,
on March 31, 2000.

                                          BentleyCapitalCorp.com Inc.

                                                   /s/ Michael Kirsh
                                          By: _________________________________
                                                       Michael Kirsh
                                                         President

  In accordance with the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates stated.



              Signature                          Title                   Date
              ---------                          -----                   ----


                                                            
        /s/ Michael Kirsh              President, Secretary,        March 31, 2000
______________________________________  Treasurer, and Director
            Michael Kirsh


                                     II-4